Glutathione may support several areas of wellness during this transition
Ian Neeland, a cardiologist at Case Western Reserve University, cautioned that in these scenarios, people should think carefully about using GLP-1s
The oral formulation is in Phase II development and the subcutaneous formulation is planned for Phase III testing in 2025
The new Medicare program covering GLP-1 weight-loss medications, Wegovy and Zepbound, has sparked significant interest and confusion among seniors
Our research points to a decline in consumption across food and beverage categories, but a more pronounced reduction in sugary drinks, confectionery, baked goods and salty snacks
GLP-1 RAs might give a person with BED respite from the cycle, while giving them skills, and having a planned taper off the medication at the end. She shared an anecdote of a patient with BED who had been taking a GLP-1 RA, who was happy with their weight loss and no longer snacked, ate excessively, or consumed high-fat and high-sugar foods